• Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • Goverment Affairs
  • 2024 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources

To Buy Xifaxan Online Visit Our Pharmacy ↓

Click HERE To Buy Xifaxan Online ↓




  • Patient Experiences: Success Stories with Xifaxan

    Understanding Xifaxan: What Patients Need to Know


    Xifaxan, generically known as rifaximin, is an antibiotic specifically designed to treat certain gastrointestinal conditions. Unlike many antibiotics, it primarily remains in the gut, minimizing systemic side effects. Patients often appreciate its focused action, especially since it's less likely to disrupt the body's overall bacterial balance. Xifaxan is FDA-approved for conditions such as irritable bowel syndrome with diarrhea (IBS-D) and traveler's diarrhea. For those battling these conditions, understanding how Xifaxan works is crucial for achieving the best outcomes.

    | Feature | Description | |-----------------|--------------------------------------------------| | Mechanism | Targets bacteria in the gut with minimal systemic absorption | | Approved Uses | IBS-D, traveler's diarrhea | | Benefits | Limited systemic side effects, gut-specific action| | Key Consideration | Works primarily within the digestive system |

    Preparation and informed discussions with healthcare providers enhance its benefits while addressing concerns. Whether just beginning this journey or exploring alternatives, patients should feel empowered with knowledge about this significant treatment option.



    Battling Sibo: a Journey to Better Health



    Navigating the complex world of Small Intestinal Bacterial Overgrowth (SIBO) can be daunting, but Xifaxan has emerged as a beacon of hope for many. As patients embark on their journey to better health, they often encounter symptoms like bloating, discomfort, and irregular bowel habits. These challenges are gradually alleviated with Xifaxan's targeted action, reducing bacterial overgrowth effectively. By restoring balance within the gut, patients report not only marked improvements in their digestive health but also renewed energy, illustrating the profound impact this treatment can bring.



    Liberation from Ibs-d: Personal Accounts of Relief


    Living with IBS-D can feel like a relentless struggle, but for some individuals, Xifaxan has been a game changer. Many patients recount stories of gradual but noticeable relief after starting their treatment regimen. It often begins with the easing of persistent symptoms—like the reduction in bowel urgency and the calming of frequent abdominal discomfort. These changes, while sometimes slow to manifest, lead to a newfound confidence in daily activities. For many, this means no longer planning outings around restroom availability. As freedom from these debilitating symptoms grows, patients report a significant improvement in their quality of life, which empowers them to reconnect with their passions and pursuits.



    Unveiling the Unexpected Benefits of Xifaxan



    For many patients, discovering the full spectrum of Xifaxan's benefits is akin to unearthing hidden treasure. While primarily prescribed for conditions like IBS-D and hepatic encephalopathy, its positive effects often extend beyond initial expectations. Patients report improved mental clarity and reduced fatigue, likely due to Xifaxan's action on gut flora, highlighting its broader impact on overall wellness. Additionally, anecdotal accounts suggest potential enhancements in mood and energy levels, offering patients unforeseen pathways to improved quality of life during treatment.



    Overcoming Setbacks: Navigating Side Effects with Support


    Navigating the journey with Xifaxan can sometimes bring unexpected challenges due to side effects. Patients have reported experiencing symptoms like nausea, headache, and abdominal pain, which can feel daunting. However, with the right support system and proactive management strategies, these hurdles can often be overcome. Communication with healthcare providers is key; they can offer personalized advice and adjustments to minimize discomfort. For instance, some have found relief by altering their diet, ensuring adequate hydration, or using complementary therapies. Online support groups also play a crucial role, providing a platform to share experiences and tips.

    Common Side Effects Management Strategies
    Nausea Adjusting diet, staying hydrated
    Headache Consulting physician, using mild pain relief
    Abdominal Pain Using warm compress, gentle exercises



    Expert Tips for Maximizing Treatment Success with Xifaxan


    Embarking on a treatment journey with Xifaxan can be daunting, but understanding and optimizing its use can significantly benefit patients. Partnering closely with healthcare providers is essential; they will tailor the treatment plan based on individual needs and monitor progress. Keeping a symptom diary enhances communication with your doctor, ensuring adjustments can be made swiftly if necessary.

    Diet plays a crucial role in the effectiveness of Xifaxan, so consider working with a dietitian to identify triggers and create a customized eating plan. Hydration is equally important, as it aids digestion and overall gut health. Incorporate probiotics with caution; consult your healthcare provider to ensure they complement your treatment rather than interfere.

    Furthermore, patience is key. While some may experience improvement quickly, allow time for Xifaxan to demonstrate its full potential. Remember, being proactive in understanding your treatment enhances the likelihood of achieving the relief you seek.





ARIZONA PSYCHIATRIC SOCIETY 2024-2025 EXECUTIVE Board

President: Nicholas Ahrendt, MD President-Elect: Margaret Balfour, MD, PhDVice President: Brenner Freeman, MDTreasurer: Robert Rymowicz, DOSecretary: Chiranjir "Ravi" Narine, MD Co Resident-Fellow Member Representatives: Nehal Samra, MD Creighton Matthew Mitchell, MD UA-PhoenixGagan Singh, MD UA-Tucson
APA Assembly Representatives: Jason Curry, DO (serves term concluding 2024) Jasleen Chhatwal, MBBS, MD (two-year term concluding 2024)Payam Sadr, MD (one-year term concluding 2024) Past President Gagandeep Singh, MD, DFAPA Stephen "Larry" Mecham, DO The Society thanks these members for their leadership.

Celebrating our members

Chase was born and raised in Phoenix, AZ, and attended ASU for a bachelor’s degree in business then attended KCUMB for medical school in Kansas City. He was excited to return home to AZ when he found out he'd been matched with UACOM – Phoenix for his psychiatry residency.
He was first drawn to the field of psychiatry during his years in medical school as he found the psychiatric subject matter and the patients to be the most engaging and interesting of all his studies. He quickly came to realize that without a healthy mind, one is unable to thoroughly experience life constructive way. He wanted to be the person to help those struggling with mental illness as he found these cases and experiences to be the most rewarding in medicine.
Dr. Crookham said he has been lucky enough to have been matched at a great psychiatric residency program where he gets to learn from great mentors and colleagues every day. He believes his passion for psychiatry along with the relationships he's developed with his colleagues and mentors will carry him to be a lifelong learner and devoted psychiatrist for his future patients.
Meghan is a graduate of Lincoln Memorial University, DeBusk College of Osteopathic Medicine.
She received her Bachelor of Arts from the University of Denver in French and Biology with a concentration in Cognitive Neuroscience.
She is currently a chief resident at UACOM-Tucson in her final year of psychiatry training and will be starting a fellowship in Addiction Medicine at the University of Arizona, Tucson in July.
Her professional interests include physician mental health, adult consult liaison and addiction psychiatry.
In her personal time, she enjoys home design projects, spending time with family, learning about plants, and exploring new places.
Dr. Hintze is currently honeymooning in Japan! Congratulations!!
Danny is originally from Phoenix. Graduated from Brophy, ASU, and UA Tucson Medical School. His background is in economics, philosophy of science, and rational decision-making.
He was drawn to psychiatry because of the conceptual complexity and the profound impact even relatively simple pharmaceutical, medical, and psychotherapeutic interventions can have to empower patients and their families.
As a mentor, he wanted to recognize the many people within the Arizona Medical Community, particularly at UA Tucson, Valleywise, and within organized medicine who have worked to protect and promote medicine as a joyful, compassionate, and healing experience for patients and for all of us who help care for them.

ARIZONA PSYCHIATRIC SOCIETY past presidents

Otto L. Bendheim, M.D. 1960-1961Warren S. Williams, M.D. 1961-1963T. Richard Gregory, M.D. 1963-1964Boris Zemsky, M.D. 1964-1965 Hal J. Breen, M.D. 1965-1966Joseph M. Green, M.D. 1966-1967Irene M. Josselyn, M.D. 1967-1968Hubert R. Estes, M.D. 1968-1969Richard H. Bruner, M.D. 1969-1970Thomas F. Kruchek, M.D. 1970-1971David S. Burgoyne Sr., M.D. 1971-1972Marshall W. Jones, M.D. 1972-1973Harold D. Haeussler, M.D. 1973-1974William B. Haeussler, M.D. 1974-1975Edward S. Gelardin, M.D. 1975-1976Hugo L. Cozzi, M.D. 1976-1977Robert F. Meyer, M.D. 1977-1978James E. Campbell, M.D. 1978-1979Stuart M. Gould, M.D. 1979-1980Elliot M. Heiman, M.D. 1980-1981Stephen V. Shanfield, M.D. 1981-1982Jerry A. Biggs, M.D. 1982-1983Robert C. Shapiro, M.D. 1983-1984Dennis C. Westin, M.D. 1984-1985John H. Jarvis, M.D. 1985-1986James G. Hill, M.D. 1986-1987Robert P. Bevan, M.D. 1987-1988Eugene J. Kinder, M.D. 1988-1989 James M. Campbell, M.D. 1989-1990David S. Burgoyne II, M.D. 1990-1991
Stuart W. Hollingsworth, M.D. 1991-1992Kevin J. Leehey, M.D. 1992-1993Stephen S. Brockway, M.D. 1993-1994Michael H. Stumpf, M.D. 1994-1995Lauro Amezcua-Patino, M.D. 1995-1996David S. Burgoyne II, M.D. 1997-1998Glenn Lippman, M.D. 1998-1999Lisa Jones, M.D. 1999-2000David J. Coons, M.D. 2000-2001James M. Campbell, M.D. 2001-2002Bradley Johnson, M.D. 2002-2003David W. Leicken, M.D. 2003-2004Thomas N. Crumbley, M.D. 2004-2006Jeffrey L. Schwimmer, M.D., M.P.H. 2006-2007Stephen O. Morris, M.D. 2007-2008Jack L. Potts, M.D. 2008-2009Elizabeth A. Kohlhepp, M.D. 2009-2010Michael E. Brennan, M.D. 2010-2011Gretchen Alexander, M.D. 2011-2012Tariq M. Ghafoor, M.D. 2012-2013Joanna K. Kowalik, M.D., M.P.H., 2013-2014Payam M. Sadr, M.D., 2014-2015Roland Segal, M.D., 2015-2016Gurjot Marwah, M.D., 2016-2017Aaron Wilson, M.D., 2017-2018Mona Amini, M.D., 2018-2019 Don J. Fowls, M.D., 2019-2020 Jasleen Chhatwal, M.B.B.S., M.D., 2020-2022 Stephen Larry Mecham, DO, 2022-2023 Gagandeep Singh, MD, DFAPA 2023-2024
Main Menu
  • Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • 2023 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources
Contact Information
Address: 2401 West Peoria Avenue, Suite 315 Phoenix, Arizona 85029
Phone: 602-909-4388
E-mail: admin@azpsych.org
Social
The Arizona Psychiatric Society is committed to ensuring the accessibility of its website to people with disabilities. If you have trouble accessing any of the Arizona Psychiatric Society's resources, please contact us at admin@azpsych.org for assistance Copyright © 2020 Network Solutions, LLC, A Web.com Company. All rights reserved.

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.